| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Klarity | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $90.53MM | Series B | 6/24/2024 | $70MM | $313.75MM | $23.22 | NFDG Ventures, Y Combinator, Tola Capital, Picus Capital, Invus Capital, Scale Venture Partners | ||||
 | Napster | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Natron Energy | Energy Energy Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $494.14MM | Series BB-6 | 12/28/2023 | $19.36MM | $761.77MM | $0.14 | Undisclosed Investors | ||||
 | Odyssey Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $413.6MM | Series D | 9/10/2025 | $213.63MM | $527.3MM | $14.62 | Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Ventures, TPG, Wedbush Healthcare Partners | ||||
 | OneTrust | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | PayJoy | Fintech Lending | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $181.77MM | Series C | 9/5/2023 | $140MM | $656.99MM | $10.24 | Warburg Pincus, Invus, Citi Ventures, Union Square Ventures, Greylock | ||||
 | Phenom People | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $184.42MM | Series E | 4/2/2026 | $50MM | $1.42B | $20.33 | Undisclosed Investors | ||||
 | Protect AI | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $129.64MM | Series B | 7/31/2024 | $80.8MM | $459.96MM | $13.26 | Evolution Equity Partners, 01 Advisors, StepStone Group, Samsung, Acrew Capital, Boldstart Ventures, Knollwood Capital, Pelion Ventures, Salesforce Ventures | ||||
 | Proteus Digital Health | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $397.36MM | Series H | 4/15/2016 | $50MM | $1.64B | $15.80 | Undisclosed Investors | ||||
 | Relay Delivery | Transportation Delivery Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Sakana AI | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Sift | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $389.17MM | Series E-1 | 9/24/2021 | $25MM | $1.84B | $25.91 | Next Coast Ventures, Primo Ventures | ||||
 | SpotOn | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $327MM | Series D | 5/26/2021 | $125MM | $1.91B | $14.95 | Andreessen Horowitz, DST Global, 01 Advisors, Dragoneer Investment Group, Franklin Templeton, Mubadala Investment Company | ||||
 | Syntiant | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $340.33MM | Series Junior | 4/10/2026 | $20.53MM | $723.68MM | $9.60 | Undisclosed Investors | ||||
 | Tango | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Tekion | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $464.8MM | Series D | 10/6/2021 | $250.01MM | $3.5B | $9.37 | Alkeon Capital, Durable Capital Partners, Hyundai Motor Company, Advent International, Index Ventures | ||||
 | Thrive AI Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Titan | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $91.95MM | Series C | 12/1/2021 | $16.98MM | $1.08B | $27.32 | Accel, B3 Capital, Dreamers VC | ||||
 | Truvian | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $204.13MM | Series D-1 Convertible | 7/17/2024 | $46.73MM | $396.91MM | $0.07 | Wittington Ventures, GreatPoint Ventures, DNS Capital, Medical Excellence Capital, Tao Capital, TYH Ventures, 7wireVentures | ||||
 | Unlearn | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $135.17MM | Series C | 2/8/2024 | $50MM | $368.17MM | $9.24 | Altimeter Capital Management, Radical Ventures, Mubadala Capital, Wittington Ventures, EPIC Ventures, Necessary Ventures, Insight Partners, 8VC, DCVC | ||||
 | What3Words | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Wunderkind | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $141.51MM | Series C | 3/2/2023 | $65.08MM | $574.54MM | $5.10 | Neuberger Berman, Disruptive Ventures | ||||
 | X-Bow | Industrial Aerospace & Defense | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $134.78MM | Series B-3 | 5/12/2025 | $32.42MM | $590.65MM | $4.08 | Lockheed Martin, Razor's Edge, Crosslink Capital, Balerion Space Ventures, Boeing Ventures, Bravo Victor Venture Capital, Upsher Management Company, Capital Factory Ventures, Arkenstone Capital, Event Horizon Capital | ||||
 | Xaira Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $1B | Series A | 4/23/2024 | $500MM | $2.65B | $2.50 | ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, Rsquared, SV Angel | ||||